⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL259113 | 0.69 | — | — | |
| SCHEMBL15689945 | 0.63 | — | — | |
| SCHEMBL623 | 0.62 | — | — | |
| SCHEMBL2043535 | 0.62 | ACHE (0.50) | — | |
| SCHEMBL2515874 | 0.61 | — | — | |
| SCHEMBL3594 | 0.61 | — | — | |
| SCHEMBL9714862 | 0.60 | — | — | |
| SCHEMBL11521189 | 0.60 | ACHE (0.47) | — | |
| SCHEMBL3887809 | 0.60 | — | — | |
| SCHEMBL22190427 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |